NeuroXess is a high-tech life science company founded in 2021, focusing on flexible electrode BCI (Brain-computer interface) technologies to protect and explore the brain. The company's slogan "Advancing brain protection and exploration with innovative flexible electrode BCI technologies" encapsulates its mission. In December 2022, NeuroXess secured a significant Series A investment with participation from notable investors including New Alliance Capital, Sailing Capital, Sequoia China, Shanda Capital, Light Silver Capital, Zhongping Capital, Qingzhou Capital, and Guosheng Group. As the company operates in the Health Care industry, its innovative approach to brain protection and exploration positions it as a compelling investment opportunity in the rapidly evolving life science sector.
No recent news or press coverage available for NeuroXess.